NANJING, CHINA: Bluestar Adisseo Company (Adisseo) said that its board of director has approved the construction of a new liquid methionine plant in Nanjing, China.
It will be the company’s third global liquid methionine platform after the first two world-class plants in Burgos, Spain and in Nanjing.
This new unit will be built in Nanjing Liuhe Chemical Park, close to the Adisseo existing plant in order to maximize synergies and take full advantage of Adisseo experience curve to manage such project and operations.
With a designed annual capacity of 180 kilotonne/y liquid methionine, the new plant is expected to start about mid-2021 in order to meet customers demand and Adisseo’s sustainable growth objectives.
BANC2 will be operated by the same management team than the current facility and will share some facilities, such as administration building, warehouse and logistic areas and utility infrastructures. This leads to lower capital and operational expenses and further improves the competitive advantages of Adisseo.
The total investment will be approximately $490 million, all funded by Adisseo’s own capital. The pay-back period is estimated to be around 4 years.
“The new project is a key step to consolidate our leadership in methionine industry. We see a steady growth rate of 6 percent per year for methionine, and the liquid methionine enjoys an even higher growth rate, with a yearly growth above 10 percent,” said Jean-Marc Dublanc, CEO of Adisseo.
“In addition, we also see the economy of scale by building another new plant in Nanjing. We can fully leverage the current local team, the experience from building and operating BANC1 as well as sharing some of the existing facilities, making it the largest liquid methionine platform operating two separated plants,” added Dublanc.
© Worldofchemicals News